Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies

Clinical trial NCT06220097 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06220097
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia B-cell Lymphoma Refractory

Start date: 2022-02-01
Primary completion: 2024-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.